Search results
Jun 6, 2024 · Browse the archive of Moderna events and presentations. Register for webcasts, or download the presentations.
3 days ago · Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine. He became CEO of Moderna in 2011 and owns a roughly 8% stake in the publicly...
5 days ago · Higher vaccine efficacy was observed with mRNA-1283 vs mRNA-1273.222 in individuals aged 65 years and older. A phase 3 trial evaluating Moderna’s next-generation COVID-19 vaccine, mRNA-1283, met its primary vaccine efficacy endpoint.
Jun 13, 2024 · Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine. mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older.
Jun 13, 2024 · June 13 (Reuters) - Moderna (MRNA.O) said on Thursday its next-generation COVID-19 vaccine candidate showed it was not inferior in efficacy compared to its approved shot in a late-stage study....
Jun 10, 2024 · Drug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a single shot, has passed a vital part of final-stage scientific checks. The phase-three trial...
Jun 11, 2024 · Afeyan has firsthand experience tackling a daunting mission: Under his watch, Moderna began developing one of the world’s first safe and effective Covid-19 vaccines in the earliest days of the...
